215 related articles for article (PubMed ID: 8622675)
1. Extensive alternative splicing and dual promoter usage generate Tcf-1 protein isoforms with differential transcription control properties.
Van de Wetering M; Castrop J; Korinek V; Clevers H
Mol Cell Biol; 1996 Mar; 16(3):745-52. PubMed ID: 8622675
[TBL] [Abstract][Full Text] [Related]
2. HIC-5 is a novel repressor of lymphoid enhancer factor/T-cell factor-driven transcription.
Ghogomu SM; van Venrooy S; Ritthaler M; Wedlich D; Gradl D
J Biol Chem; 2006 Jan; 281(3):1755-64. PubMed ID: 16291758
[TBL] [Abstract][Full Text] [Related]
3. The human LEF-1 gene contains a promoter preferentially active in lymphocytes and encodes multiple isoforms derived from alternative splicing.
Hovanes K; Li TW; Waterman ML
Nucleic Acids Res; 2000 May; 28(9):1994-2003. PubMed ID: 10756202
[TBL] [Abstract][Full Text] [Related]
4. The human high mobility group (HMG)-box transcription factor TCF-1: novel isoforms due to alternative splicing and usage of a new exon IXA.
Mayer K; Wolff E; Clevers H; Ballhausen WG
Biochim Biophys Acta; 1995 Aug; 1263(2):169-72. PubMed ID: 7640309
[TBL] [Abstract][Full Text] [Related]
5. The human T cell transcription factor-1 gene. Structure, localization, and promoter characterization.
van de Wetering M; Oosterwegel M; Holstege F; Dooyes D; Suijkerbuijk R; Geurts van Kessel A; Clevers H
J Biol Chem; 1992 Apr; 267(12):8530-6. PubMed ID: 1569101
[TBL] [Abstract][Full Text] [Related]
6. Lymphoid enhancer factor 1 directs hair follicle patterning and epithelial cell fate.
Zhou P; Byrne C; Jacobs J; Fuchs E
Genes Dev; 1995 Mar; 9(6):700-13. PubMed ID: 7537238
[TBL] [Abstract][Full Text] [Related]
7. Differential importin-alpha recognition and nuclear transport by nuclear localization signals within the high-mobility-group DNA binding domains of lymphoid enhancer factor 1 and T-cell factor 1.
Prieve MG; Guttridge KL; Munguia J; Waterman ML
Mol Cell Biol; 1998 Aug; 18(8):4819-32. PubMed ID: 9671491
[TBL] [Abstract][Full Text] [Related]
8. T-cell factor 4N (TCF-4N), a novel isoform of mouse TCF-4, synergizes with beta-catenin to coactivate C/EBPalpha and steroidogenic factor 1 transcription factors.
Kennell JA; O'Leary EE; Gummow BM; Hammer GD; MacDougald OA
Mol Cell Biol; 2003 Aug; 23(15):5366-75. PubMed ID: 12861022
[TBL] [Abstract][Full Text] [Related]
9. An enhancer LEF-1/TCF-1 site is essential for insertion site-independent transgene expression in thymus.
Haynes TL; Thomas MB; Dusing MR; Valerius MT; Potter SS; Wiginton DA
Nucleic Acids Res; 1996 Dec; 24(24):5034-44. PubMed ID: 9016677
[TBL] [Abstract][Full Text] [Related]
10. Ectopic activation of lymphoid high mobility group-box transcription factor TCF-1 and overexpression in colorectal cancer cells.
Mayer K; Hieronymus T; Castrop J; Clevers H; Ballhausen WG
Int J Cancer; 1997 Aug; 72(4):625-30. PubMed ID: 9259402
[TBL] [Abstract][Full Text] [Related]
11. The human TCF-1 gene encodes a nuclear DNA-binding protein uniquely expressed in normal and neoplastic T-lineage lymphocytes.
Castrop J; van Wichen D; Koomans-Bitter M; van de Wetering M; de Weger R; van Dongen J; Clevers H
Blood; 1995 Oct; 86(8):3050-9. PubMed ID: 7579399
[TBL] [Abstract][Full Text] [Related]
12. Functional diversity of Xenopus lymphoid enhancer factor/T-cell factor transcription factors relies on combinations of activating and repressing elements.
Gradl D; König A; Wedlich D
J Biol Chem; 2002 Apr; 277(16):14159-71. PubMed ID: 11821382
[TBL] [Abstract][Full Text] [Related]
13. Tcf binding sequence and position determines beta-catenin and Lef-1 responsiveness of MMP-7 promoters.
Gustavson MD; Crawford HC; Fingleton B; Matrisian LM
Mol Carcinog; 2004 Nov; 41(3):125-39. PubMed ID: 15457508
[TBL] [Abstract][Full Text] [Related]
14. Lymphoid enhancer factor/T cell factor expression in colorectal cancer.
Waterman ML
Cancer Metastasis Rev; 2004; 23(1-2):41-52. PubMed ID: 15000148
[TBL] [Abstract][Full Text] [Related]
15. Tcf/Lef transcription factors during T-cell development: unique and overlapping functions.
Staal FJ; Clevers H
Hematol J; 2000; 1(1):3-6. PubMed ID: 11920163
[TBL] [Abstract][Full Text] [Related]
16. Purification of TCF-1 alpha, a T-cell-specific transcription factor that activates the T-cell receptor C alpha gene enhancer in a context-dependent manner.
Waterman ML; Jones KA
New Biol; 1990 Jul; 2(7):621-36. PubMed ID: 2083253
[TBL] [Abstract][Full Text] [Related]
17. A functional screen in human cells identifies UBF2 as an RNA polymerase II transcription factor that enhances the beta-catenin signaling pathway.
Grueneberg DA; Pablo L; Hu KQ; August P; Weng Z; Papkoff J
Mol Cell Biol; 2003 Jun; 23(11):3936-50. PubMed ID: 12748295
[TBL] [Abstract][Full Text] [Related]
18. An alternative polyadenylation signal in TCF7L2 generates isoforms that inhibit T cell factor/lymphoid-enhancer factor (TCF/LEF)-dependent target genes.
Locke JM; Da Silva Xavier G; Rutter GA; Harries LW
Diabetologia; 2011 Dec; 54(12):3078-82. PubMed ID: 21913056
[TBL] [Abstract][Full Text] [Related]
19. Alternative promoter usage and splicing options result in the differential expression of mRNAs encoding four isoforms of chicken VBP, a member of the PAR subfamily of bZIP transcription factors.
Burch JB; Davis DL
Nucleic Acids Res; 1994 Nov; 22(22):4733-41. PubMed ID: 7984425
[TBL] [Abstract][Full Text] [Related]
20. Positive and negative roles of the trans-acting T cell factor-1 for the acquisition of distinct Ly-49 MHC class I receptors by NK cells.
Kunz B; Held W
J Immunol; 2001 May; 166(10):6181-7. PubMed ID: 11342639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
